Cited by 646Colorectal Cancer Screening and DetectionAI in cancer detectionColorectal Cancer Surgical Treatments

Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial

Repici, Alessandro, Badalamenti, Matteo, Maselli, Roberta, Correale, Loredana, Radaelli, Franco, Rondonotti, Emanuele, Ferrara, Elisa, Spadaccini, Marco +16 more·2020·Gastroenterology

Abstract

Background & aims One-fourth of colorectal neoplasias are missed during screening colonoscopies; these can develop into colorectal cancer (CRC). Deep learning systems allow for real-time computer-aided detection (CADe) of polyps with high accuracy. We performed a multicenter, randomized trial to assess the safety and efficacy of a CADe system in detection of colorectal neoplasias during real-time colonoscopy.Methods We analyzed data from 685 subjects (61.32 ± 10.2 years old; 337 men) undergoing screening colonoscopies for CRC, post-polypectomy surveillance, or workup due to positive results from a fecal immunochemical test or signs or symptoms of CRC, at 3 centers in Italy from September through November 2019. Patients were randomly assigned (1:1) to groups who underwent high-definition colonoscopies with the CADe system or without (controls). The CADe system included an artificial intelligence-based medical device (GI-Genius, Medtronic) trained to process colonoscopy images and superimpose them, in real time, on the endoscopy display a green box over suspected lesions. A minimum withdrawal time of 6 minutes was required. Lesions were collected and histopathology findings were used as the reference standard. The primary outcome was adenoma detection rate (ADR, the percentage of patients with at least 1 histologically proven adenoma or carcinoma). Secondary outcomes were adenomas detected per colonoscopy, non-neoplastic resection rate, and withdrawal time.Results The ADR was significantly higher in the CADe group (54.8%) than in the control group (40.4%) (relative risk [RR], 1.30; 95% confidence interval [CI], 1.14-1.45). Adenomas detected per colonoscopy were significantly higher in the CADe group (mean, 1.07 ±1.54) than in the control group (mean 0.71 ± 1.20) (incidence rate ratio, 1.46; 95% CI, 1.15-1.86). Adenomas 5 mm or smaller were detected in a significantly higher proportion of subjects in the CADe group (33.7%) than in the control group (26.5%; RR, 1.26; 95% CI, 1.01-1.52), as were adenomas of 6 to 9 mm (detected in 10.6% of subjects in the CADe group vs 5.8% in the control group; RR, 1.78; 95% CI, 1.09-2.86), regardless of morphology or location. There was no significant difference between groups in withdrawal time (417 ± 101 seconds for the CADe group vs 435 ± 149 for controls; P = .1) or proportion of subjects with resection of non-neoplastic lesions (26.0% in the CADe group vs 28.7% of controls; RR, 1.00; 95% CI, 0.90-1.12).Conclusions In a multicenter, randomized trial, we found that including CADe in real-time colonoscopy significantly increases ADR and adenomas detected per colonoscopy without increasing withdrawal time. ClinicalTrials.gov no: 04079478.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2020.04.062

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Repici, A., Badalamenti, M., Maselli, R., Correale, L., Radaelli, F., Rondonotti, E., Ferrara, E., Spadaccini, M., Alkandari, A., Fugazza, A., Anderloni, A., Galtieri, P. A., Pellegatta, G., Carrara, S., Di Leo, M., Craviotto, V., Lamonaca, L., Lorenzetti, R., Andrealli, A., Antonelli, G., Wallace, M., Sharma, P., Rosch, T., & Hassan, C.
Affiliations
  • IRCCS Humanitas Research Hospital (IT)
  • Ospedale Valduce (IT)
  • Mayo Clinic in Florida (US)
  • United States Department of Veterans Affairs (US)
Corresponding author
Repici, Alessandro
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2020-08
Volume
159
Issue
2
Pages
512-520.e7
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3021812344
Cited by
646
References
21
Citations by year
2026: 101 · 2025: 102 · 2024: 84 · 2023: 113 · 2022: 121 · 2021: 92 · 2020: 31 · 2017: 1
FWCI
32.24
Type
journal article
Language
en
Open access
closed
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords
computer-aided detection, colorectal neoplasia, colorectal adenoma detection, colorectal cancer screening, colonoscopy, deep learning, GI Genius, small adenomas, polyp detection, withdrawal time, post-polypectomy surveillance, artificial intelligence in endoscopy, missed lesions, fecal immunochemical test
MeSH terms
Deep Learning, Adenoma, Aged, Biopsy, Colon, Colonoscopy, Female, Humans, Image Interpretation, Computer-Assisted, Male, Mass Screening, Middle Aged, Time Factors, Colorectal Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review